Matrix metalloproteinases as biomarkers and treatment targets in mesothelioma : a systematic review

Štrbac, Danijela (author), Dolžan, Vita (author)

Metalloproteinases (MMPs) have an important role in tissue remodeling and have been shown to have an effect on tumor progression, invasion, metastasis formation, and apoptosis in several tumors, including mesothelioma. Mesothelioma is a rare tumor arising from pleura and peritoneum and is frequently associated with asbestos exposure. We have performed a systematic search of PubMed.gov and ClinicalTrials.gov databases to retrieve and review three groups of studies: studies of MMPs expression in tumor tissue or body fluids in patients with mesothelioma, studies of MMPs genetic variability, and studies of MMPs as potential novel drug targets in mesothelioma. Several studies of MMPs in mesothelioma tissues reported a link between higher expression levels of commonly studied MMPs and clinical parameters, such as overall survival. Fewer studies have investigated genetic variability of MMP genes. Nevertheless, these studies suggested that certain genetic variants in MMP genes can have either protective or tumor-promoting effects on mesothelioma patients. MMPs have been also reported as novel drug targets, but so far no clinical trials of MMP inhibitors are registered in mesothelioma. In conclusion, MMPs play an important role in mesothelioma, but further studies are needed to elucidate the potentials of MMPs as biomarkers and drug targets in mesothelioma.

• Language: English
• Keywords: mesothelioma, metalloproteinases, genetic variability, biomarker, drug target
• Work type: Article
• Typology: 1.02 - Review Article
• Organization: MF - Faculty of Medicine
• Publication status: Published
• Publication version: Version of Record
• Year: 2021
• Number of pages: 10 str.
• Numbering: Vol. 11, iss. 9, art. 1272
• PID: 20.500.12556/RUL-136046
• UDC: 616-006
• ISSN on article: 2218-273X
• DOI: 10.3390/biom11091272
• COBISS.SI-ID: 74658819
• Publication date in RUL: 08.04.2022

ŠTRBAC, Danijela and DOLŽAN, Vita, 2021, Matrix metalloproteinases as biomarkers and treatment targets in mesothelioma : a systematic review. Biomolecules [online]. 2021. Vol. 11, no. 9,  1272. [Accessed 1 April 2025]. DOI 10.3390/biom11091272. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=136046

Record is a part of a journal

• Title: Biomolecules
• Shortened title: Biomolecules
• Publisher: MDPI AG
• ISSN: 2218-273X
• COBISS.SI-ID: 519952921

Licences

• License: CC BY 4.0, Creative Commons Attribution 4.0 International
• Link: http://creativecommons.org/licenses/by/4.0/
• Description: This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
• Licensing start date: 01.09.2021

Secondary language

• Language: Slovenian
• Keywords: mezoteliom, metaloproteinaza, genetska variabilnost